275 results on '"Anderstam, Björn"'
Search Results
2. Total and bone-specific alkaline phosphatase are associated with bone mineral density over time in end-stage renal disease patients starting dialysis
3. Inflammation down-regulates CYP3A4-catalysed drug metabolism in hemodialysis patients
4. Associations between amino acids and bone mineral density in men with idiopathic osteoporosis
5. Serum soluble CD36, assessed by a novel monoclonal antibody-based sandwich ELISA, predicts cardiovascular mortality in dialysis patients
6. Autologous Peripheral Blood Mononuclear Cells as Treatment in Refractory Acute Respiratory Distress Syndrome
7. The kidney is the major site of S-adenosylhomocysteine disposal in humans
8. Lipid Peroxide Levels in a Murine Adenocarcinoma Exposed to Hyperthermia: The Role of Glutathione Depletion
9. Effects of Acute Fructose Loading on Markers of Inflammation—A Pilot Study
10. Macrophage Migration Inhibitory Factor (MIF) and Thyroid Hormone Alterations in Antineutrophil Cytoplasmic Antibody (ANCA)-Associated Vasculitis (AAV)
11. Elevated serum levels of S-adenosylhomocysteine, but not homocysteine, are associated with cardiovascular disease in stage 5 chronic kidney disease patients
12. Modification of the oxidative stress biomarker AOPP assay: Application in uremic samples
13. Chapter 6 Vascular Calcification Inhibitors In Relation To Cardiovascular Disease With Special Emphasis On Fetuin‐A In Chronic Kidney Disease
14. Plasma S100A12 and soluble receptor of advanced glycation end product levels and mortality in chronic kidney disease Stage 5 patients
15. Overestimation of advanced oxidation protein products in uremic plasma due to presence of triglycerides and other endogenous factors
16. Cytokines
17. Circulating vascular endothelial growth factor (VEGF) and its soluble receptor 1 (sVEGFR-1) are associated with inflammation and mortality in incident dialysis patients
18. Effect of Bicarbonate on Muscle Protein in Patients Receiving Hemodialysis
19. Plasma Reduced Homocysteine and Other Aminothiol Concentrations in Patients With CKD
20. Changes in circulating biomarkers during a single hemodialysis session
21. Clinical importance of an elevated circulating chemerin level in incident dialysis patients
22. Visfatin is increased in chronic kidney disease patients with poor appetite and correlates negatively with fasting serum amino acids and triglyceride levels
23. Inflammation contributes to low plasma amino acid concentrations in patients with chronic kidney disease
24. Associations of VEGF and its receptors sVEGFR-1 and -2 with cardiovascular disease and survival in prevalent haemodialysis patients
25. The Metabolism of Glutathione and its Related Dipeptides across Kidney, Splanchnic organs and Lung in Humans: 511
26. Enhanced RAGE-mediated NFκB stimulation in inflamed hemodialysis patients
27. Review on uraemic toxins III: recommendations for handling uraemic retention solutes in vitro—towards a standardized approach for research on uraemia
28. Hyperhomocysteinemia in relation to plasma free amino acids, biomarkers of inflammation and mortality in patients with chronic kidney disease starting dialysis therapy
29. THE ISOLATION OF ANOREXIA ASSOCIATED UREMIC TOXINS FROM EFFLUENT OF CARD PATIENTS
30. Plasma Pentosidine Is Associated with Inflammation and Malnutrition in End-Stage Renal Disease Patients Starting on Dialysis Therapy
31. Heat sterilization of peritoneal dialysis solutions influences ingestive behavior in non-uremic rats
32. Influence of nutritional status on plasma and erythrocyte sulphur amino acids, sulph-hydryls, and inorganic sulphate in end-stage renal disease
33. Acute effects of peritoneal dialysis solutions on appetite in non-uremic rats
34. Kinetic studies of dipeptide-based and amino acid-based peritoneal dialysis solutions
35. Hyperhomocysteinemia and its relationship to cardiovascular disease in ESRD: Influence of hypoalbuminemia, malnutrition, inflammation, and diabetes mellitus
36. Hyperhomocysteinemia, nutritional status, and cardiovascular disease in hemodialysis patients
37. Evidence of taurine depletion and accumulation of cysteinesulfinic acid in chronic dialysis patients
38. Influence of peritoneal dialysis solutions with glucose and amino acids on ingestive behavior in rats
39. Effects of acute fructose loading on levels of serum uric acid-a pilot study
40. Brown adipose tissue in young adults who were born preterm or small for gestational age
41. Restrictive lung disorder is common in patients with kidney failure and associates with protein-energy wasting, inflammation and cardiovascular disease
42. Skin autofluorescence, arterial stiffness and Framingham risk score as predictors of clinical outcome in chronic kidney disease patients: a cohort study
43. Serum Glutaredoxin Activity as a Marker of Oxidative Stress in Chronic Kidney Disease: A Pilot Study
44. Skin autofluorescence, arterial stiffness and Framingham risk score as predictors of clinical outcome in chronic kidney disease patients: a cohort study.
45. Plasma Beta-Trace Protein as a Marker of Residual Renal Function: The Effect of Different Hemodialysis Modalities and Intra-Individual Variability over Time
46. Plasma Pentosidine and Its Association with Mortality in Patients with Chronic Kidney Disease
47. MP528SKIN AUTOFLUORESCENCE (SAF), A MARKER OF TISSUE ADVANCED GLYCATED END-PRODUCTS (AGE), AND ARTERIAL STIFFNESS IN PERITONEAL DIALYSIS PATIENTS
48. SP286PLASMA BETA TRACE PROTEIN PREDICTS MORTALITY IN CKD: RELATION WITH ENDOTHELIAL DYSFUNCTION
49. MP666INFLAMMATION DOWN REGULATES CYTOCHROME P450 MEDINATED DRUG METABOLISM IN HEMODIALYSIS PATIENTS
50. Elevated Circulating S100A12 Associates with Vascular Disease and Worse Clinical Outcome in Peritoneal Dialysis Patients
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.